Triall (TRL) is a token of an end-to-end platform for data collection and research management. Triall solutions are designed to support any therapeutic area, research design, and research phase. The platform offers advanced integration capabilities with websites, mobile devices and wearables to support remote data collection and study management.

Triall (TRL) news

Triall

Twitter

#TRLInsights - Biotech is on the rise.

Since 2021, 60% of novel therapies approved by the @US_FDA are biotech products.

Moreover, global sales of #biotech products have consistently increased since 2018, surpassing $466 billion in 2022.

Source: https://t.co/T45Dv1Hzfb

#TRLInsights - Biotech is on the rise. Since 2021, 60% of novel therapies approved by the @US_FDA are biotech products.